Cancer cases set to overwhelm global health systems in the coming decades

Publicly released:
Australia; VIC
Photo by National Cancer Institute on Unsplash
Photo by National Cancer Institute on Unsplash

The world is set to be short 100 million workers in the field of cancer care by 2050, according to a Lancet Oncology Commission. The report projects future cancer cases, finding diagnoses are likely to increase by 21% from last year to 2050 with low and middle-income countries set to bear the brunt. The report predicts low five-year survival rates across Africa and Asia into the mid-21st century, while high-income countries are expected to see survival of over 60%. The researchers say work needs to be done now to invest in the technology and workforce development needed to handle the increase in cancer diagnoses in the future.

News release

From: La Trobe University

Global cancer care workforce gap to hit 100 million

A global report has warned of an impending shortage of nearly 100 million cancer care workers by 2050.

The Lancet Oncology Commission warns the shortfall, driven by rising cancer rates and workforce gaps, will place significant strain on health systems worldwide, with the largest shortages expected in nursing and diagnostic roles.

Professor Andrew Scott, from Melbourne’s Olivia Newton-John Cancer Research Institute affiliated with La Trobe University as the School of Cancer Medicine, was the only Australian researcher on the international commission.

Currently an estimated one in three cancers are undiagnosed worldwide, with more than 60 per cent of cancers remaining undiagnosed in some regions of Africa.

The study projects a continuing inequality in survival outcomes, with significantly lower survival rates projected in low and middle-income regions, such as Africa (34 per cent) and Asia (39 per cent), while reaching beyond 60 per cent in high-income areas such as North America and Oceania.

Professor Scott’s clinical and research interests are focused on developing innovative strategies for targeted therapies and molecular imaging in oncology. He said addressing workforce shortages, particularly in medical imaging, was critical to improving outcomes in Australia and around the world.

“Identifying gaps in the workforce for imaging of cancer patients is essential to ensuring correct diagnoses and treatments are available for patients in all countries,” Professor Scott said.

In Australia, the findings highlight the importance of investing in imaging services and workforce capacity, particularly in regional areas where access can be limited.
Professor Scott said medical imaging must be available across Australia as early identification of cancer was primarily through imaging studies.

“Medical imaging is essential for the active treatment of cancer patients and workforce requirements are a key component of delivering safe and effective treatment in the Australian healthcare system,” Professor Scott said.

The Cancer workforce - a global crisis: a Lancet Oncology Commission calls for urgent national and global action, including stronger workforce planning, targeted investment in training and expanded access to diagnostic and treatment services to meet growing demand.

The report finds that scaling up the cancer workforce could avert up to 170 million deaths and cut mortality by about 40 per cent, while delivering significant economic benefits.

Multimedia

Andrew Scott
Andrew Scott

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research The Lancet, Web page The URL will go live after the embargo ends
Journal/
conference:
The Lancet Oncology
Research:Paper
Organisation/s: La Trobe University, Olivia Newton-John Cancer Research Institute, The University of Melbourne
Funder: HH was partly supported by a National Institutes of Health–National Cancer Institute cancer centre support grant P30 CA008748 to Memorial Sloan Kettering Cancer Center.
Media Contact/s
Contact details are only visible to registered journalists.